Post-sanctions Iran attracts pharma investment
January 26, 2016Manufacturing and Production, Sales and Marketing Gulf Co-operation Council, Iran, Isral, Saudi Arabia, United Arab Emirates, middle east
Just a few days have passed since decade-long economic sanctions on Iran were lifted, as the middle-eastern powerhouse agreed to …
GSK and Sanofi considering developing Zika vaccine
January 26, 2016Manufacturing and Production GSK, Sanofi, World Health Organisation, Zika virus, microcephaly
Pharma companies Sanofi and GSK are reviewing the possibility of using their respective inoculation technologies to develop a vaccine for …
UK Government commits £1 billion to malaria fight
January 26, 2016Manufacturing and Production Bill Gates, Chancellor, George Osborne, Ross Fund, infectious diseases, malaria
Chancellor George Osborne has set out details of a billion pound fund to develop, test and produce new products to …
Shire tries again with lifitegrast dry eye FDA application
January 25, 2016Manufacturing and Production, Sales and Marketing FDA, Shire, dry eye disease, lifitegrast
Shire has resubmitted its New Drug Application (NDA) to the US FDA for its rejected dry eye syndrome drug lifitegrast. …
Avacta appoints Philippe Cotrel as chief commercial officer
January 25, 2016Manufacturing and Production, Research and Development Avacta
Cotrel joins Avacta from Abcam, where he held the role of commercial operations director.He will lead the Group’s commercial strategy …
New chief exec at MannKind
January 25, 2016Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer
The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …
AbbVie VP joins UCB Pharma
January 25, 2016Manufacturing and Production, Research and Development, Sales and Marketing Pascale Richetta, UCB, UCB Pharma
Pascale Richetta will join the UCB as its new head of the bone therapy patient value unit as from February …
Cancer Research UK appoints Professor Sir Bruce Ponder as trustee
January 25, 2016Research and Development Cancer Research UK, Professor Sir Bruce Ponder
Cancer Research UK has appointed Professor Sir Bruce Ponder as a trustee. Ponder is emeritus professor of oncology at Cambridge …
Amgen earns first Japanese nod for PCSK9 inhibitor
January 25, 2016Sales and Marketing Amgen, Astellas, Japan, PCSK9 inhibitor, Repatha, evolocumab, high cholesterol
The Japanese Ministry of Health, Labour and Welfare has approved Amgen’s cholesterol-lowering medication Repatha, in a joint venture between Amgen …
The case for leaders with scientific acumen in pharma
January 25, 2016Medical Communications, Research and Development research and development
Pharmaceutical companies are currently undergoing fundamental, disruptive changes to conventional research and development models. This is in an attempt to …
Big pharma and UK universities launch £40m innovation fund
January 25, 2016Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture
A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …
Researchers raise TPP legislation concerns
January 25, 2016Manufacturing and Production, Sales and Marketing Legislation, Trans-Pacific Partnership, tpp, trade agreement
Academics have warned that global trade regulations under consideration by the US and other countries could prevent access to medicines …
FDA approves new uses for BMS’ Opdivo/Yervoy cancer combo
January 25, 2016Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilimumabm melanoma, nivolumab, opdivo, skin cancer
The FDA has granted Bristol Myers Squibb an expanded indication for its two-cancer drug regimen Opdivo and Yervoy, to treat …
AbbVie and MD Anderson in cancer research partnership
January 25, 2016Research and Development, Sales and Marketing AbbVie, MD Anderson Cancer Centre, immuno-oncology
AbbVie has announced a new partnership with The University of Texas MD Anderson Cancer Centre, using its immunotherapy platform to …
Patients sue J&J for $800m for ‘hiding antibiotic side effects’
January 22, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Janssen, Johnson and Johnson, Levaquin, Margaret Hamburg, lawsuit, levofloxacin
Six users of Johnson & Johnson’s antibiotic Levaquin are to sue the company for up to $870 million, claiming the …
California hospital becomes first to prescribe digital pill
January 22, 2016Medical Communications california, digital health, digital pill, ingestible pill, proteus
Proteus Digital Health, the first company to have a ‘digital pill’ approved by the FDA, has signed its first deal …
FDA approves new Kyprolis combo for multiple myeloma
January 22, 2016Medical Communications, Sales and Marketing Amgen, FDA, Kyprolis, carfilzomib, multiple myeloma, myeloma
Amgen’s Kyprolis has been given another endorsement by the FDA as a multiple myeloma treatment – its second in six …
Merck appoints Jessie English to lead discovery team
January 22, 2016Research and Development Jessie English, Merck
Merck has appointed Jessie English as the new vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. …
NICE ‘yes’ for BMS skin cancer drug Opdivo
January 22, 2016Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, NICE, melanoma, nivolumab, opdivo, skin cancer
NICE has approved Bristol-Myers Squibb’s skin cancer immunotherapy Opdivo (nivolumab) in final draft guidance as monotherapy for NHS patients in England …
Martin Shkreli subpoenaed in US to testify over drug pricing
January 21, 2016Medical Communications, Sales and Marketing Daraprim, Howard Schiller, Martin Shkreli, Valeant, turing
Former pharma chief exec Martin Shkreli has been issued with a subpoena by the US House of representatives, compelling him …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
